Surgery, Gastroenterology and Oncology
Vol. 25, No. 5, Dec 2020
Results of an Enhanced Recovery after Surgery Protocol for Upper Gastrointestinal Surgery at a Super-Tertiary Referral Hospital in Thailand
Thammawat Parakonthun, Thikhamporn Tawantanakorn, Jirawat Swangsri, Tharathorn Suwatthanarak, Nicha Srisuworanan, Voraboot Taweerutchana, Chainarong Phalanusitthepa, Atthaphorn Trakarnsanga, Thawatchai Akaraviputh, Asada Methasate, Vitoon Chinswangwatanakul
ORIGINAL PAPER, Dec 2020
Article DOI: 10.21614/sgo-25-5-248
Background: Enhanced recovery after surgery (ERAS) protocol has been shown to reduce recovery period and postoperative complications. This prospective study aimed to evaluate the short-term outcomes of ERAS in patients who underwent upper gastrointestinal (UGI) surgery.

Methods: Patients who underwent surgery for benign or malignant diseases of the esophagus, esophagogastric junction, or stomach during October 2018-December 2019 were included. Outcomes compared between ERAS and conventional care (CC) included length of hospital stay (LOS), postoperative complications, mortality, recovery, and hospitalization cost.

Results: Eighty-eight (32 ERAS, 56 CC) patients were included. ERAS had shorter LOS (5.5 vs. 12.5 days, p<0.001), earlier time to toleration of oral soft diet (3 vs. 8 days, p<0.001), faster time to first defecation (71.6 vs. 114.5 hours, p<0.001), early ambulation (43.8 vs. 84.6 hours, p=0.010), and reduced hospitalization cost (197,140 vs. 256,315 Thai baht, p<0.032).
C-reactive protein level on postoperative day 1 was significantly lower in ERAS patients (61.3 vs. 87.9 mg L, p=0.027). BMI recovery occurred within 3 and 6 months in ERAS and CC, respectively. There was no significant difference in surgery-related or nonsurgery- related complications between groups. No mortality was observed.

Conclusions: In a UGI surgical setting, ERAS accelerated recovery, reduced LOS, and lowered hospitalization cost.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3485


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.